Literature DB >> 34232141

Recent lessons learned for ex-vivo platelet production.

Alice Tang1, Avital Mendelson.   

Abstract

PURPOSE OF REVIEW: Platelet transfusion can be life-saving but carries a risk of infection or alloimmunization and is limited by insufficient donor sources and restricted unit shelf life. Generating sufficient platelets in vitro to replace a unit of collected blood remains a challenge. Here, we examine the latest advances in the regulation of megakaryocyte maturation and expansion along with platelet formation and survival. We also discuss alternative therapies investigated to induce platelet production. RECENT
FINDINGS: Recent studies examined candidate niche cells in the bone marrow microenvironment for promoting platelet formation and developed an explant-based bioreactor to enhance platelet production ex vivo. Chemical inhibitors were examined for their ability to promote megakaryocyte maturation and expansion. Microparticles from megakaryocytes or platelets were found to improve megakaryocyte maturation and platelet formation. Membrane budding was identified as a novel mode of platelet formation. Lastly, a chemical inhibitor to improve cold-stored platelets was identified.
SUMMARY: Recent advances in the regulation of megakaryocyte expansion and platelet production provide exciting promise for the development of improved approaches to generate platelets in vitro. These findings bring the field one step closer to achieving the ultimate goal of creating a unit of platelets without the need for donation.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 34232141      PMCID: PMC8490274          DOI: 10.1097/MOH.0000000000000662

Source DB:  PubMed          Journal:  Curr Opin Hematol        ISSN: 1065-6251            Impact factor:   3.284


  62 in total

1.  Residual risk of bacterial contamination of platelets: six years of experience with sterility testing.

Authors:  Sandra Ramirez-Arcos; Caesar DiFranco; Terri McIntyre; Mindy Goldman
Journal:  Transfusion       Date:  2017-06-26       Impact factor: 3.157

2.  Platelet microparticles are internalized in neutrophils via the concerted activity of 12-lipoxygenase and secreted phospholipase A2-IIA.

Authors:  Anne-Claire Duchez; Luc H Boudreau; Gajendra S Naika; James Bollinger; Clémence Belleannée; Nathalie Cloutier; Benoit Laffont; Raifish E Mendoza-Villarroel; Tania Lévesque; Emmanuelle Rollet-Labelle; Matthieu Rousseau; Isabelle Allaeys; Jacques J Tremblay; Patrice E Poubelle; Gérard Lambeau; Marc Pouliot; Patrick Provost; Denis Soulet; Michael H Gelb; Eric Boilard
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-23       Impact factor: 11.205

3.  Pathophysiology of thrombocytopenia and anemia in mice lacking transcription factor NF-E2.

Authors:  J Levin; J P Peng; G R Baker; J L Villeval; P Lecine; S A Burstein; R A Shivdasani
Journal:  Blood       Date:  1999-11-01       Impact factor: 22.113

4.  Mice lacking transcription factor NF-E2 provide in vivo validation of the proplatelet model of thrombocytopoiesis and show a platelet production defect that is intrinsic to megakaryocytes.

Authors:  P Lecine; J L Villeval; P Vyas; B Swencki; Y Xu; R A Shivdasani
Journal:  Blood       Date:  1998-09-01       Impact factor: 22.113

5.  Molecular cloning and chromosomal localization of the human thrombopoietin gene.

Authors:  Y Sohma; H Akahori; N Seki; T Hori; K Ogami; T Kato; Y Shimada; K Kawamura; H Miyazaki
Journal:  FEBS Lett       Date:  1994-10-10       Impact factor: 4.124

6.  Prolonged continuous in vitro human platelet production using three-dimensional scaffolds.

Authors:  Brent Sullenbarger; Joong Hwan Bahng; Ryan Gruner; Nicholas Kotov; Larry C Lasky
Journal:  Exp Hematol       Date:  2008-11-13       Impact factor: 3.084

7.  Transcription factor NF-E2 is required for platelet formation independent of the actions of thrombopoietin/MGDF in megakaryocyte development.

Authors:  R A Shivdasani; M F Rosenblatt; D Zucker-Franklin; C W Jackson; P Hunt; C J Saris; S H Orkin
Journal:  Cell       Date:  1995-06-02       Impact factor: 41.582

8.  Microfluidic model of the platelet-generating organ: beyond bone marrow biomimetics.

Authors:  Antoine Blin; Anne Le Goff; Aurélie Magniez; Sonia Poirault-Chassac; Bruno Teste; Géraldine Sicot; Kim Anh Nguyen; Feriel S Hamdi; Mathilde Reyssat; Dominique Baruch
Journal:  Sci Rep       Date:  2016-02-22       Impact factor: 4.379

9.  Cytoskeletal-based mechanisms differently regulate in vivo and in vitro proplatelet formation.

Authors:  Alicia Bornert; Julie Boscher; Fabien Pertuy; Anita Eckly; David Stegner; Catherine Strassel; Christian Gachet; François Lanza; Catherine Léon
Journal:  Haematologica       Date:  2021-05-01       Impact factor: 9.941

10.  An inhibition of p38 mitogen activated protein kinase delays the platelet storage lesion.

Authors:  Andrey Skripchenko; Helen Awatefe; Dedeene Thompson-Montgomery; Andrew Myrup; Annette Turgeon; Stephen J Wagner
Journal:  PLoS One       Date:  2013-08-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.